27647762|t|Theranostic Upconversion Nanobeacons for Tumor mRNA Ratiometric Fluorescence Detection and Imaging - Monitored Drug Delivery
27647762|a|Remote optical detection and imaging of specific tumor -related biomarkers and simultaneous activation of therapy according to the expression level of the biomarkers in tumor site with theranostic probes should be an effective modality for treatment of cancers. Herein, an upconversion nanobeacon (UCNPs - MB / Dox) is proposed as a new theranostic nanoprobe to ratiometrically detect and visualize the thymidine kinase 1 (TK1) mRNA that can simultaneously trigger the Dox release to activate the chemotherapy accordingly. UCNPs - MB / Dox is constructed with the conjugation of a TK1 mRNA -specific molecular beacon (MB) bearing a quencher (BHQ-1) and an alkene handle modified upconversion nanoparticle (UCNP) through click reaction and subsequently loading with a chemotherapy drug (Dox). With this nanobeacon, quantitative ratiometric upconversion detection of the target with high sensitivity and selectivity as well as the target triggered Dox release in vitro is demonstrated. The sensitive and selective ratiometric detection and imaging of TK1 mRNA under the irradiation of near infrared light (980 nm) and the mRNA -dependent release of Dox for chemotherapy in the tumor MCF-7 cells and A549 cells are also shown. This work provides a smart and robust platform for gene -related tumor theranostics.
27647762	0	36	Theranostic Upconversion Nanobeacons	T091	C4042913
27647762	41	46	Tumor	T191	C0027651
27647762	47	51	mRNA	T114,T123	C0035696
27647762	52	86	Ratiometric Fluorescence Detection	T060	C0430876
27647762	91	98	Imaging	T060	C0025086
27647762	101	110	Monitored	T058	C0184514
27647762	111	124	Drug Delivery	T058	C1881966
27647762	125	149	Remote optical detection	T170	C0449335
27647762	154	161	imaging	T060	C0011923
27647762	174	179	tumor	T191	C0027651
27647762	189	199	biomarkers	T201	C0005516
27647762	204	216	simultaneous	T079	C0521115
27647762	217	227	activation	T052	C1879547
27647762	231	238	therapy	T061	C0087111
27647762	256	266	expression	T045	C1171362
27647762	280	290	biomarkers	T201	C0005516
27647762	294	299	tumor	T191	C0027651
27647762	300	304	site	T029	C1515974
27647762	310	328	theranostic probes	T130	C0026381
27647762	342	351	effective	T080	C1704419
27647762	352	360	modality	T078	C0695347
27647762	365	385	treatment of cancers	T061	C0920425
27647762	398	421	upconversion nanobeacon	T073	C1450054
27647762	423	428	UCNPs	T073	C1450054
27647762	431	433	MB	T114,T123	C2350253
27647762	436	439	Dox	T109,T195	C0013089
27647762	444	452	proposed	T080	C1553874
27647762	462	483	theranostic nanoprobe	T073	C1881978
27647762	487	509	ratiometrically detect	T061	C1511790
27647762	514	523	visualize	T169	C0234621
27647762	528	546	thymidine kinase 1	T028	C1420747
27647762	548	551	TK1	T028	C1420747
27647762	553	557	mRNA	T114,T123	C0035696
27647762	567	581	simultaneously	T079	C0521115
27647762	582	589	trigger	T052	C1879547
27647762	594	597	Dox	T109,T195	C0013089
27647762	609	617	activate	T052	C1879547
27647762	622	634	chemotherapy	T061	C3665472
27647762	648	653	UCNPs	T073	C1450054
27647762	656	658	MB	T114,T123	C2350253
27647762	661	664	Dox	T109,T195	C0013089
27647762	689	700	conjugation	T043	C1160466
27647762	706	709	TK1	T028	C1420747
27647762	710	714	mRNA	T114,T123	C0035696
27647762	725	741	molecular beacon	T114,T123	C2350253
27647762	743	745	MB	T114,T123	C2350253
27647762	757	765	quencher	T109,T130	C4041998
27647762	767	772	BHQ-1	T109,T130	C4041998
27647762	781	787	alkene	T109	C0002068
27647762	795	803	modified	T169	C0392747
27647762	804	829	upconversion nanoparticle	T073	C1450054
27647762	831	835	UCNP	T073	C1450054
27647762	845	859	click reaction	T070	C2936296
27647762	892	909	chemotherapy drug	T109,T121	C0003392
27647762	911	914	Dox	T109,T195	C0013089
27647762	927	937	nanobeacon	T073	C1450054
27647762	939	951	quantitative	T081	C0392762
27647762	952	986	ratiometric upconversion detection	T061	C1511790
27647762	994	1000	target	T169	C1521840
27647762	1006	1010	high	T080	C0205250
27647762	1011	1022	sensitivity	T080	C1522640
27647762	1027	1038	selectivity	T052	C1707391
27647762	1054	1060	target	T169	C1521840
27647762	1061	1070	triggered	T052	C1879547
27647762	1071	1074	Dox	T109,T195	C0013089
27647762	1083	1091	in vitro	T080	C1533691
27647762	1095	1107	demonstrated	T059	C1148554
27647762	1113	1122	sensitive	T169	C0332324
27647762	1127	1158	selective ratiometric detection	T061	C1511790
27647762	1163	1170	imaging	T060	C0011923
27647762	1174	1177	TK1	T028	C1420747
27647762	1178	1182	mRNA	T114,T123	C0035696
27647762	1193	1204	irradiation	T037	C0015333
27647762	1213	1227	infrared light	T074	C0181645
27647762	1245	1249	mRNA	T114,T123	C0035696
27647762	1272	1275	Dox	T109,T195	C0013089
27647762	1280	1292	chemotherapy	T061	C3665472
27647762	1300	1305	tumor	T191	C0027651
27647762	1306	1317	MCF-7 cells	T025	C0596890
27647762	1322	1332	A549 cells	T025	C4277577
27647762	1359	1367	provides	T052	C1999230
27647762	1380	1386	robust	T080	C2986815
27647762	1400	1404	gene	T028	C0017337
27647762	1414	1419	tumor	T191	C0027651
27647762	1420	1432	theranostics	T061	C0087111